Alex M

353 posts

Alex M banner
Alex M

Alex M

@a_miloski

Building #DeSci ㆍ Looking for the cure @vitadao ㆍ Automating science @aubrai_ㆍ Supporting founders @beakerdaoㆍ Investor by-heart

Network Katılım Haziran 2018
2.7K Takip Edilen794 Takipçiler
Kevin Xu
Kevin Xu@kevinxu·
how do i have an $11.2m net worth in mid-30s without inheritance? 1. no vacations 2. shop at costco 3. only drink water 4. never tip at cafes 5. go all in 1 stock at a time
Kevin Xu tweet media
English
190
61
1.5K
244.5K
Alex M
Alex M@a_miloski·
Been a long building season at @vitadao. a few updates: 1/ VitaApp is in private alpha. selected community members being served first, public release follows shortly. this will be the first VitaDAO consumer app, with our own longevity AI engine built in @Aubrai_ . health optimization grounded in research; encrypted end to end to preserve users privacy - finally an app like this will come into existence. 2/ Aubrai is our AI agent built to accelerate the science itself. generates hypotheses, sends them to CROs for validation, pays scientists when results land. closing a native AI-to-wet-lab integration soon. 3/ VitaRNA, one of our first IPT projects, is developing tRNA suppressor gene therapies for nonsense mutations tied to aging. led by Michael Torres, who just recently sold his last biotech company to Eli Lilly in a deal worth up to $300M. VitaRNA was funded with $91K from vitadao + $300K via IPT sale, partnered with Lonza for GMP manufacturing. lead candidate ARTAN-102 just showed 350x liver expression in vivo. next stop: primate toxicity. 4/ the portfolio is moving too: Gero (backed in 2023) signed Roche's Chugai in July 2025. up to ~$250M in milestones, 1B+ potential with royalties, for AI-discovered antibody targets in age-related disease. platform trained on 100M+ longitudinal medical records. 5/ Rubedo (backed in 2021) is also making progress on AI. their ALEMBIC platform reads single-cell data from primary human tissue to find pathologic senescent cells. SenTech then designs the molecule against them. result: RLS-1496, the first GPX4 modulator ever dosed in humans (May 2025). positive Phase 1 readouts in psoriasis, atopic dermatitis and photo-aged skin came in March 2026. Phase 2a coming. 6/ and we're rebuilding VitaLabs, VitaDAO's incubation program into a fully AI-native longevity biotech venture studio. tiny founding teams, $100-150K, 6-9-month proof factories with CROs and pharma BD pre-wired from day one. cohort 1 capped at 3 projects. whitepaper out soon. Crypto compounds capital, AI compounds intelligence and biotech compounds biology. we're building where the three meet.
English
1
7
33
3.1K
Alex M retweetledi
Michael Torres
Michael Torres@Mykalt45·
Attention $vitarna token-holders and the DeSci: I’ve been a tad busy with my other company! That said, we’ve been cooking quite a bit with @artan_bio and Vitarna! I hope you all are ready for the ride! To spell it out: with CrossBridge I took a project that was in the university 3 years ago and with $10M in VC money I turned that into a $300M buyout from the world’s most valuable pharma. We’re pushing on the same things for vitarna token-holders! When you do it it, this can be the outcome! Going to show the world what we’re capable of! I’ll be personally investing in Artan, too, and hope to raise through the token as well! @vitadao @vitarnabio @Molecule_sci @alxdobrin @paulkhls
English
3
5
32
3.9K
Alex M retweetledi
Brian Armstrong
Brian Armstrong@brian_armstrong·
Aging is arguably the root cause of most major diseases. Our cells lose function as we age, allowing various conditions to manifest, which is why most major diseases correlate with age. Yes, it is more complex than this, but this is a major component. @newlimit is working on treating a root cause of disease (aging) using epigenetic reprogramming.
Brian Armstrong tweet media
English
258
270
2.6K
276.1K
Alex M retweetledi
ResearchHub Foundation
ResearchHub Foundation@ResearchHubF·
Something huge just landed at @ResearchHub. Introducing: Endowments. Starting today, everyone holding ResearchCoin (RSC) in their ResearchHub account will automatically earn high-yield Funding Credits, distributed daily. Funding Credits must be used to support projects on ResearchHub, turning your one-time investment into a continuous source of research funding.
English
5
23
73
32K
Alex M retweetledi
Molecule
Molecule@Molecule_sci·
In early March, we met with the SEC Crypto Task Force. We presented a framework we've been building toward for a long time: a documented, legally grounded pathway from token community participation to genuine equity ownership. Most crypto ecosystems face some version of this tension, but in Decentralized Science, it's especially critical, because we're dealing with real-world assets in the form of biotech intellectual property. Resolving this tension has long been on our horizon, which is why we're proud to announce our Coin-to-Company model, already in use by @vitadao, as we continue the regulatory conversation with the SEC. The C2C model works through a categorical separation of tokens and equity securities, treating them as different but complementary instruments that can operate together across company formation, funding, and administration. Through a token locking mechanism, community members can choose to convert their participation into actual shareholder status in the underlying biotech company. All tokenholders remain part of a project-focused DAO throughout. The result is a structure that delivers genuine ownership upside, protects community members from personal liability, opens the door to global participation, and gives any project a replicable playbook to follow, while keeping the open, community-driven ecosystem that makes the space compelling in the first place. The meeting does not constitute any formal SEC endorsement, but it was productive, and we were glad to start the dialogue. Read the announcement & let us know what you think.
Molecule@Molecule_sci

x.com/i/article/2034…

English
5
26
29
7.4K
Alex M retweetledi
VitaDAO 💛
VitaDAO 💛@vitadao·
Biology is starting to look a lot more like engineering. For longevity, that means faster learning loops, better models, and more shots on goal. That’s the future we’re building toward with @aubrai_ as an AI co-scientist for longevity research.
Dustin@r0ck3t23

Jensen Huang just called the exact top of the pharmaceutical industry. Not a pivot. Not a disruption. An extinction event. Huang: “Where do I think the next amazing revolution is going to come? And this is going to be flat out one of the biggest ones ever. There’s no question that digital biology is going to be it.” The medical establishment has spent centuries playing a chaotic game of trial and error. We’re about to mathematically engineer the human operating system. Huang: “For the very first time in human history, biology has the opportunity to be engineering, not science. When something becomes engineering, not science, it becomes less sporadic and exponentially improving.” Biology is no longer the dark art of random discovery. It’s a predictable, compounding execution loop. Translate the chaotic variables of chemistry into the laws of computer science and you stop waiting for accidental breakthroughs. You simply compute the cure. That line should terrify every pharmaceutical executive alive. Huang: “It can compound on the benefits of the previous years. And every researcher’s contributions compound on each other.” For decades, drug discovery has been an isolated, artisanal process. One lab. One team. One molecule. Years of blind iteration. The algorithm just shattered that entire bottleneck. Every failed protein fold, every successful synthetic molecule instantly trains the foundational model. Makes the next iteration mathematically smarter. Huang: “We’re going to have incredible tools that bring the world of biology, which is very chaotic and constantly changing and diverse and complex, into the world of computer science. And that is going to be profound.” Incumbent pharma looks at the human body and sees an unmanageable wall of variables. Engineers look at that exact same body and see raw data waiting to be compiled. No longer guessing how a molecule will react in the physical world. Running millions of zero-cost simulated iterations before a single test tube is ever touched. Rip the chaotic friction out of the physical lab and drop it directly into a massive GPU cluster? The timeline to map, edit, and optimize the biological machine doesn’t shrink. It collapses.

English
16
7
61
5.2K
Alex M retweetledi
Naval
Naval@naval·
It’s not about junior vs senior, it’s about “good with AI” vs “not good with AI.”
English
926
1.9K
17.8K
903.3K
Alex M retweetledi
Paul Kohlhaas bio/acc
Paul Kohlhaas bio/acc@paulkhls·
Love this! Working toward an integration for @BioProtocol
Jason Kelly@jrkelly

Excited to launch the @Ginkgo Cloud Lab service today! Recently, GPT-5 ordered experiments from Ginkgo's autonomous lab in our work with @OpenAI below -- now we're making our lab available to users (or their AI models) in the cloud to order lab experiments and get back data online. Play around with it now! You can ask our agent about your protocol and it will do its best to evaluate if we can run it and what it would cost. cloud.ginkgo.bio/protocols To start we've launched 3 Ginkgo Certified Protocols, two around cell free protein expression and one to make bacterial pixel art 😀 We will be adding new protocols weekly -- at first ones we certify, but eventually users will order whatever experiment they want as long as we have the needed equipment on our autonomous lab! We hope that Cloud Labs will someday allow anyone to be a scientist with their own lab just like personal computers and cloud data centers democratized programming and the web. More in thread 🧵and happy to answers Qs if you post!

English
10
11
95
7.9K
Alex M
Alex M@a_miloski·
The (only?) bullish thesis for crypto moving forward: serve as the rails for an AI-native economy: agents transact in stables, pay blockchain fees, accumulate surplus in BTC & treasury-manage in DeFi. BTC = proxy for GDP & agents get taxed directly in it.
English
0
1
2
50
Alex M
Alex M@a_miloski·
accelerate *everything*
English
0
0
3
68
Alex M
Alex M@a_miloski·
RT @vitadao: .@Aubrai is now SOTA for longevity research. Trained on decades of aging research, private lab notes, and insights from Dr. A…
English
0
1
0
35